Cambridge startup wins £100k for bionics project
Cambridge Bio-Augmentation Systems (CBAS), a startup developing a platform technology for bionics, has won an Innovate UK grant of £100,000.
The eight-month grant will allow CBAS to automate remote monitoring of lower limb disorders or amputations to improve treatment and rehabilitation in patients with prosthetics.
Bionics is the study of mechanical systems that function like living organisms or parts of living organisms.
CBAS co-founder Oliver Armitage (pictured) said: “This is a really exciting time for digital health to use technology to help make care more personalised and accurate.
“By leveraging the power of machine learning and bionics we can convey relevant health metrics to clinicians and improve patients’ lives by giving them more control.”
The continuous remote monitoring system is being developed for use with orthoses and prostheses to enable clinicians to access real-time assessment of biomechanics and mobility metrics of their patients. This will inform and improve treatment decisions and help patients have more personalised and tailored care for their needs.
Current clinical assessment is restricted to one-off hospital visits and patient self-reporting questionnaires; remote treatment monitoring systems are set to be an integral part of future healthcare strategies. The project will explore the commercial and technical feasibility of a continuous remote monitoring system.
CBAS is supported by the Serious Impact incubator in Cambridge and has offices at Allia Future Business Centre.